National Bank of Canada’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-333
Closed -$894 2900
2022
Q4
$894 Hold
333
﹤0.01% 2593
2022
Q3
$2K Buy
+333
New +$2.34K ﹤0.01% 2555

Other funds holding BTCY

National Bank of Canada's BTCY Position: Q1 2023 in Review

National Bank of Canada sold out of Biotricity, Inc. Common Stock (BTCY) in Q1 2023, closing a stake of 333 shares — an estimated $894 sold.

National Bank of Canada first reported a position in BTCY in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 28 funds tracked by Wall St. Rank hold BTCY as of Q1 2023.

  • National Bank of Canada reported no remaining Biotricity, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • National Bank of Canada sold 333 Biotricity, Inc. Common Stock shares in Q1 2023, an estimated $894.
  • National Bank of Canada first reported a position in Biotricity, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • National Bank of Canada's Biotricity, Inc. Common Stock position peaked at $2K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.